Literature DB >> 25594641

Improved health-related quality of life after surgical management of severe refractory constipation-dominant irritable bowel syndrome.

Jennifer Y Lam1, Biniam Kidane, Farouq Manji, Brian M Taylor.   

Abstract

Irritable bowel syndrome (IBS) is the most common of the functional gastrointestinal disorders (FGIDs). Despite its prevalence and health-care costs, there are few effective therapies for patients with severe symptoms. Our objective was to determine whether surgical management would improve health-related quality of life (HRQOL) in severe refractory constipation-dominant FGIDs. From 2003 to 2005, 6 patients underwent total colectomy with end ileostomy or primary anastomosis. They completed Short Form 36 (SF-36) and IBS-36 questionnaires preoperatively and postoperatively. HRQOL was compared with age- and sex-matched Canadian norms using Welch's unpaired t test. Preoperative SF-36 physical and mental health summary scores were significantly lower than Canadian norms (P < 0.0001), while postoperative scores were not significantly different than Canadian norms (P = 0.50 and P = 0.57, respectively). After surgical management, HRQOL in patients with severe constipation-dominant IBS improved from drastically below that of Canadian norms to a comparable level. This finding questions the convention of avoiding operations in IBS patients and demonstrates that surgical management may be suitable for the appropriately screened patient.

Entities:  

Keywords:  Health-related quality of life; Irritable bowel syndrome; Surgery

Mesh:

Year:  2015        PMID: 25594641      PMCID: PMC4301295          DOI: 10.9738/INTSURG-D-13-00212.1

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  34 in total

1.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

2.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

3.  Co-morbidities and survival of men with localized prostate cancer treated with surgery or radiation therapy.

Authors:  J E Fowler; F L Terrell; D L Renfroe
Journal:  J Urol       Date:  1996-11       Impact factor: 7.450

4.  Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome.

Authors:  Hans Törnblom; Greger Lindberg; Björn Nyberg; Béla Veress
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

5.  Validation of the Charlson comorbidity index in patients with head and neck cancer: a multi-institutional study.

Authors:  B Singh; M Bhaya; J Stern; J T Roland; M Zimbler; R M Rosenfeld; G Har-El; F E Lucente
Journal:  Laryngoscope       Date:  1997-11       Impact factor: 3.325

6.  Validating the SF-36 health survey questionnaire: new outcome measure for primary care.

Authors:  J E Brazier; R Harper; N M Jones; A O'Cathain; K J Thomas; T Usherwood; L Westlake
Journal:  BMJ       Date:  1992-07-18

7.  Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer.

Authors:  O Birim; A P W M Maat; A P Kappetein; J P van Meerbeeck; R A M Damhuis; A J J C Bogers
Journal:  Eur J Cardiothorac Surg       Date:  2003-01       Impact factor: 4.191

Review 8.  Systematic review: Abdominal and pelvic surgery in patients with irritable bowel syndrome.

Authors:  W L Hasler; P Schoenfeld
Journal:  Aliment Pharmacol Ther       Date:  2003-04       Impact factor: 8.171

9.  Irritable bowel syndrome and surgery: a multivariable analysis.

Authors:  George F Longstreth; Janis F Yao
Journal:  Gastroenterology       Date:  2004-06       Impact factor: 22.682

10.  The impact of comorbidity on the overall survival and the cause of death in patients after colorectal cancer resection.

Authors:  Ralf Joachim Rieker; Eva Hammer; Roland Eisele; Eberhardt Schmid; Josef Högel
Journal:  Langenbecks Arch Surg       Date:  2002-04-30       Impact factor: 3.445

View more
  1 in total

1.  Use of Serotonergic Drugs in Canada for Gastrointestinal Motility Disorders: Results of a Retrospective Cohort Study.

Authors:  Biniam Kidane; Farouq Manji; Jennifer Lam; Brian M Taylor
Journal:  Scientifica (Cairo)       Date:  2016-05-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.